{"id":161441,"date":"2026-11-04T23:43:14","date_gmt":"2026-11-04T23:43:14","guid":{"rendered":"https:\/\/irakezen.nl\/du\/who-staat-gebruik-van-twee-nieuwe-ebolavaccins-toe-in-zwaar-getroffen-congo\/"},"modified":"2026-11-04T23:43:14","modified_gmt":"2026-11-04T23:43:14","slug":"who-staat-gebruik-van-twee-nieuwe-ebolavaccins-toe-in-zwaar-getroffen-congo","status":"publish","type":"post","link":"https:\/\/irakezen.nl\/du\/who-staat-gebruik-van-twee-nieuwe-ebolavaccins-toe-in-zwaar-getroffen-congo\/","title":{"rendered":"WHO staat gebruik van twee nieuwe ebolavaccins toe in zwaar getroffen Congo"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/images.nu.nl\/m\/t45xjmca4s34_sqr256\/1312\/8\/3736\/3736\/who-staat-gebruik-van-twee-nieuwe-ebolavaccins-toe-in-zwaar-getroffen-congo.jpg\" \/><br \/>De Wereldgezondheidsorganisatie (<a href=\"https:\/\/www.who.int\/news\/item\/04-11-2026-two-new-candidate-vaccines-to-join-ebola-trial-as-treatment-research-advances\" target=\"_blank\">WHO<\/a>) heeft goedkeuring gegeven om klinische testen uit te voeren met twee nieuwe ebolavaccins in de Democratische Republiek Congo. Het gaat om de eerste vaccins die speciaal zijn ontwikkeld tegen de bundibugyovariant van het virus.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>De Wereldgezondheidsorganisatie (WHO) heeft goedkeuring gegeven om klinische testen uit te voeren met twee nieuwe ebolavaccins in de Democratische Republiek Congo. Het gaat om de eerste vaccins die speciaal zijn ontwikkeld tegen de bundibugyovariant van het virus.<\/p>\n","protected":false},"author":19,"featured_media":161442,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[147],"tags":[],"class_list":["post-161441","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nederland"],"_links":{"self":[{"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/posts\/161441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/comments?post=161441"}],"version-history":[{"count":0,"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/posts\/161441\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/media\/161442"}],"wp:attachment":[{"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/media?parent=161441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/categories?post=161441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irakezen.nl\/du\/wp-json\/wp\/v2\/tags?post=161441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}